Key result
Among patients prescribed oral anticoagulants, 86.6% demonstrated high adherence at 6 months, with the presence of a caretaker being the most important contributing factor.
Why the study?
Oral anticoagulants are effective for patients at risk of thromboembolism, but there are limited data from India on their use and adherence.
Observational (n=140)
No
In an Indian tertiary care setting, adherence to oral anticoagulants was high at 6 months and strongly facilitated by the presence of a caretaker, though compliance with monthly INR monitoring was poor.
Despite high adherence, poor INR monitoring compliance cautions against assuming full OAC safety; leaves open need for prospective trials.
Background: In patients at risk of thromboembolism, oral anticoagulants (OAC) are effective, but there are limited data from India on OAC use and adherence. This study in a tertiary care hospital aims to record the pattern of prescription of OAC and medication adherence over 6 months. Materials and Methods: Medications prescribed were recorded, and a follow-up at 3 and 6 months was done to record outcomes and adherence to medication. Modified Morisky medication adherence scale (MMAS-8) was used and compliance to monthly International Normalized Ratio (INR) monitoring was recorded. Results: Of the 140 patients included, mean age was 55.32 (±18.04 years), and 84 (60.0%) were males. Indications for OAC were deep vein thrombosis 64 (45.7%) and atrial fibrillation 42 (30.0%). After initial injectable anticoagulants, majority of patients were shifted to Vitamin K antagonists. Most common OAC was nicoumarol 73 (52.1%), followed by warfarin 43 (30.2%), dabigatran 12 (9.2%), and apixaban 12 (9.2%). Over 6 months, 12 patients were lost to follow-up and 16 (11.4%) deaths were recorded. Monthly INR was done by 23 patients till the 3 rd month but only by five patients between 3 rd and 6 th month. By the 3 rd month, 19 (86.3%) and between 3 rd and 6 th month 4 (13.7%) patients were nonadherent. At 6 th month, 78 (86.6%) had a MMAS-8 score of 8 (high adherence). The presence of a caretaker in 37 (41.2%) emerged as the most important factor contributing to adherence. Conclusion: Early identification of patient-specific barriers for INR monitoring and adherence to medications should be sought in patients with thromboembolism.
No takes yet. Share an insight, caveat, or question.
Pradhyumna et al. (2021) conducted an observational in Thromboembolism (n=140). Oral anticoagulants was evaluated on High adherence (MMAS-8 score of 8) at 6 months. Among patients prescribed oral anticoagulants, 86.6% demonstrated high adherence at 6 months, with the presence of a caretaker being the most important contributing factor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: